Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)

Urology

Volumn 42, Issue 2, 1993, Pages 119-130

  Denis, L J ^a,b,c,d,e,f   Carneiro De Moura, J L ^a,b,c,d,e,f   Bono, A ^a,b,c,d,e,f   Sylvester, R ^a,b,c,d,e,f   Whelan, P ^a,b,c,d,e,f   Newling, D ^a,b,c,d,e,f   Depauw, M ^a,b,c,d,e,f  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c HOSPITAL DE SANTA MARIA   (Portugal)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e OSPEDALE DI CIRCOLO   (Italy)

^f EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTAMIDE; GOSERELIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; FLUSHING; GASTROINTESTINAL TOXICITY; GYNECOMASTIA; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; ORCHIECTOMY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; BONE NEOPLASMS; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; FLUTAMIDE; FOLLOW-UP STUDIES; GOSERELIN; HUMAN; MALE; MIDDLE AGE; ORCHIECTOMY; PROGNOSIS; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS;

EID: 0027182961     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/0090-4295(93)90634-M     Document Type: Article

References (16)

1. Bilateral adrenalectomy in prostatic cancer. Clinical features and urinary excretion of 17ketosteroids and estrogen
2. Current status of bilateral adrenalectomy for advanced prostatic cancer
3. Antiandrogens in the treatment of prostatic cancer
4. EORTC protocol 30805: A phase-III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low-dose stilboestrol in the management of metastatic carcinoma of the prostate
5. A complete androgen blockade for the treatment of prostate cancer
6. Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma
7. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
8. The TNM classification of prostate cancer
9. Prostatic cancer: an overview
10. Rationale for surgical castration
11. Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma
12. A phase III randomized study of a depot GnRH agonist (Zoladex) vs diethylstilbestrol 3 mg per day in advanced prostatic cancer
13. Zoladex and flutamide versus bilateral orchiectomy. A randomized phase III EORTC 30853 study